The pharmaceutical company will donate money for each strike-out made by the team’s pitcher for the remainder of the regular season.

AbbVie and ADARx Pharmaceuticals have announced a multi-billion dollar ... ADARx’s co-founder, president and chief executive officer, Zhen Li, added that the collaboration “further validates the ...

Collaboration to leverage AbbVie’s expertise in biotherapeutic drug development and commercialization together with ADARx’s proprietary RNA technology ... benefit of patients worldwide,” said Zhen Li, ...

AbbVie and ADARx Pharmaceuticals, a late clinical-stage biotechnology ... to accelerate these programs for the potential benefit of patients worldwide,” said Zhen Li, Ph.D., co-founder, president and ...

AbbVie (NYSE: ABBV), a global biopharmaceutical company with a market capitalization of $332 billion and annual revenue exceeding $57 billion, has entered into a strategic collaboration with ADARx ...